AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14769702 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/d
Number of subjects: 37
Study 14769702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 10935954 — intervention group
Group type: EXPERIMENTAL
Intervention: Class II elastics (Begg technique)
Number of subjects: 36
Study 10935954 — intervention group
Group type: COMPARATOR
Intervention: Fixed functional appliances (Herbst appliance)
Number of subjects: 36
Study 10935954 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 8937662 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand system supplying compressed air from high pressure cylinders using a demand valve
Number of subjects: 9
Study 8937662 — intervention group
Group type: COMPARATOR
Intervention: Ambient room air (control)
Number of subjects: 9
Study 8937662 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand system supplying compressed air
Number of subjects: 9
Study 8237845 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula supplemented with taurine (479 mumol/L)
Number of subjects: 30
Study 3768270 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapists who made accurate predictions of patient behavior
Number of subjects: 0
Study 3768270 — intervention group
Group type: COMPARATOR
Intervention: Therapists who made reflections or requested further information
Number of subjects: 0
Study 3768270 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapists who employed accurate predictions
Number of subjects: 0
Study 31666076 — intervention group
Group type: EXPERIMENTAL
Intervention: Revefenacin 175 μg
Number of subjects: 1055
Study 31666076 — intervention group
Group type: EXPERIMENTAL
Intervention: Revefenacin 88 μg
Number of subjects: 1055
Study 31666076 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium (active control)
Number of subjects: 1055
Study 31666076 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms (including Revefenacin and Tiotropium)
Number of subjects: 1055
Study 28259621 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Through Choices (PTC) intervention
Number of subjects: 1036
Study 26386635 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of health care providers using the '20‐Hour Course For Maternity Staff'
Number of subjects: 422
Study 26386635 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 422
Study 22850475 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention bias scores for children with no diagnosis (n = 1411)
Number of subjects: 1774
Study 22850475 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention bias scores for children with distress-related disorders (n = 66)
Number of subjects: 1774
Study 22850475 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention bias scores for children with fear-related disorders (n = 86)
Number of subjects: 1774
Study 22850475 — intervention group
Group type: COMPARATOR
Intervention: Attention bias scores for children with behavior disorders (n = 211)
Number of subjects: 1774
Study 22077985 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary education programme (MEP)
Number of subjects: 12
Study 22077985 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary education programme (MEP) followed by individual consultations
Number of subjects: 12
Study 19716483 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered single‐cone technique (SC) in ProTaper (subgroup A1)
Number of subjects: 80
Study 19716483 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral condensation (LC) in ProTaper (subgroup A2)
Number of subjects: 80
Study 19716483 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm vertical compaction (WVC) in ProTaper (subgroup A3)
Number of subjects: 80
Study 19716483 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered single‐cone technique (SC) in Mtwo (subgroup B1)
Number of subjects: 80
Study 19716483 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral condensation (LC) in Mtwo (subgroup B2)
Number of subjects: 80
Study 19716483 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm vertical compaction (WVC) in Mtwo (subgroup B3)
Number of subjects: 80
Study 16442873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention school (Phase 1)
Number of subjects: 2
Study 16442873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention school (Phase 2)
Number of subjects: 2
Study 16442873 — intervention group
Group type: COMPARATOR
Intervention: Control school (Phase 2)
Number of subjects: 2
Study 15263100 — intervention group
Group type: EXPERIMENTAL
Intervention: Cessation of creatine supplementation with reduced-volume training (33% lower volume)
Number of subjects: 8
Study 15263100 — intervention group
Group type: COMPARATOR
Intervention: Control group (no creatine supplementation)
Number of subjects: 8
Study 11745278 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg daily
Number of subjects: 1021
Study 11745278 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen 20 mg daily
Number of subjects: 1021
Study 9052812 — intervention group
Group type: COMPARATOR
Intervention: 0 microg CNTF/kg
Number of subjects: 18
Study 9052812 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 microg CNTF/kg
Number of subjects: 18
Study 9052812 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 microg CNTF/kg
Number of subjects: 18
Study 8109937 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin (T) systemic prophylaxis - 800 mg in 100 ml saline as a 5-min infusion 2.5 h before surgery
Number of subjects: 24
Study 8109937 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin (T) regional prophylaxis - 400 mg in 100 ml saline as a 5-min infusion immediately after tourniquet inflation
Number of subjects: 24
Study 8109937 — intervention group
Group type: COMPARATOR
Intervention: Control group (systemic prophylaxis)
Number of subjects: 24
Study 3518641 — intervention group
Group type: EXPERIMENTAL
Intervention: ORS60‐Gly110
Number of subjects: 3
Study 3518641 — intervention group
Group type: EXPERIMENTAL
Intervention: ORS60‐Gly60
Number of subjects: 3
Study 3518641 — intervention group
Group type: COMPARATOR
Intervention: ORS60
Number of subjects: 3
Study 30014828 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 248
Study 30014828 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 248
Study 30014828 — intervention group
Group type: COMPARATOR
Intervention: Cotrimoxazole
Number of subjects: 248
Study 30014828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study 26438637 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Autism Program (CAP)
Number of subjects: 302
Study 26438637 — intervention group
Group type: COMPARATOR
Intervention: business as usual programs
Number of subjects: 302
Study 25070100 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin 600 mg once daily for 6 days
Number of subjects: 0
Study 25070100 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 200 mg once daily for 7 days
Number of subjects: 0
Study 21745832 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 120
Study 21745832 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 120
Study 21745832 — intervention group
Group type: COMPARATOR
Intervention: Gabapentin
Number of subjects: 120
Study 21745832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 20210262 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion intervention at worksites
Number of subjects: 341
Study 20210262 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 341
Study 18710624 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective Ventilation (PV) group
Number of subjects: 40
Study 18710624 — intervention group
Group type: COMPARATOR
Intervention: Conventional Ventilation (CV) group
Number of subjects: 40
Study 15867643 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% saline spray
Number of subjects: 8
Study 15867643 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0% saline spray
Number of subjects: 8
Study 12532101 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab (at least 0.016 mg/kg/IgE [IU/mL], administered subcutaneously every 4 weeks)
Number of subjects: 1405
Study 12532101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1405
Study 9895077 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine hydrochloride 0.01% administered via IV regional anesthesia (IVRA)
Number of subjects: 12
Study 8892538 — intervention group
Group type: EXPERIMENTAL
Intervention: Slosson Oral Reading Test‐Revised
Number of subjects: 123
Study 8892538 — intervention group
Group type: EXPERIMENTAL
Intervention: Woodcock Reading Mastery Test‐Revised
Number of subjects: 123
Study 8892538 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide Range Achievement Test‐Revised
Number of subjects: 123
Study 1705685 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients participating in self-care through nurse-patient interaction in addition to usual care (Experimental group)
Number of subjects: 40
Study 1705685 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 40
Study 6660205 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture on the normal side and rehabilitation (flection-extension exercise and massage on the affected joint)
Number of subjects: 0
Study 6660205 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture on the affected part of the affected side with rehabilitation on the affected part of the affected side
Number of subjects: 0
Study 6660205 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and rehabilitation
Number of subjects: 0
Study 6660205 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture on the normal side and rehabilitation on the affected part of the affected side
Number of subjects: 0
Study 31802525 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60
Study 31802525 — intervention group
Group type: COMPARATOR
Intervention: Tramadol
Number of subjects: 60
Study 30853645 — intervention group
Group type: EXPERIMENTAL
Intervention: Anise oil
Number of subjects: 0
Study 30853645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28924371 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 72
Study 28924371 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 72
Study 26743526 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg selenium supplements (n=30)
Number of subjects: 60
Study 25140995 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole treatment (30 mg daily for at least 1 month, followed by titration)
Number of subjects: 145
Study 25140995 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole treatment with L-thyroxine (30 mg daily for at least 1 month, followed by titration with L-thyroxine)
Number of subjects: 145
Study 21809168 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (10-30 mg/day)
Number of subjects: 374
Study 21809168 — intervention group
Group type: COMPARATOR
Intervention: RLAI (25-50 mg i.m. every 2 weeks)
Number of subjects: 374
Study 19220543 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacilli
Number of subjects: 359
Study 19220543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 359
Study 17615501 — intervention group
Group type: EXPERIMENTAL
Intervention: HFA-BDP
Number of subjects: 77
Study 17615501 — intervention group
Group type: COMPARATOR
Intervention: FP
Number of subjects: 77
Study 14744821 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands and knees position and pelvic rocking exercises from 37 weeks' gestation until the onset of labour
Number of subjects: 2547
Study 14744821 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 2547
Study 14744821 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands and knees position and pelvic rocking exercises
Number of subjects: 2547
Study 12616822 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 150 mg kg‐1 bolus followed by continuous infusion of 12 mg kg‐1 h‐1
Number of subjects: 93
Study 12616822 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% dextrose)
Number of subjects: 93
Study 9836566 — intervention group
Group type: EXPERIMENTAL
Intervention: Streamtest cup
Number of subjects: 50
Study 9836566 — intervention group
Group type: COMPARATOR
Intervention: Formal in-office uroflow study
Number of subjects: 50
Study 7934757 — intervention group
Group type: EXPERIMENTAL
Intervention: Physically active commuting to work (PACW) 1 h daily for 10 weeks
Number of subjects: 68
Study 2738277 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program for spouses of Alzheimer's patients
Number of subjects: 40
Study 2738277 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 40
Study 31111439 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera mouthwash
Number of subjects: 152
Study 31111439 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea tree oil mouthwash
Number of subjects: 152
Study 31111439 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash
Number of subjects: 152
Study 31111439 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 152
Study 31666039 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine reminder and tracker bracelets (two types of silicone bracelets)
Number of subjects: 1446
Study 31666039 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1446
Study 27794485 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 24
Study 26254683 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy plus surgery
Number of subjects: 366
Study 26254683 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 366
Study 26254683 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy plus surgery (squamous cell carcinoma)
Number of subjects: 366
Study 26254683 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (squamous cell carcinoma)
Number of subjects: 366
Study 26254683 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy plus surgery (adenocarcinoma)
Number of subjects: 366
Study 26254683 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (adenocarcinoma)
Number of subjects: 366
Study 23497359 — intervention group
Group type: EXPERIMENTAL
Intervention: Feel the ViBe
Number of subjects: 0
Study 23497359 — intervention group
Group type: COMPARATOR
Intervention: Minimally Enhanced Usual Care (mEUC)
Number of subjects: 0
Study 21228267 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy children without CF)
Number of subjects: 34
Study 21228267 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with cystic fibrosis (CF)
Number of subjects: 34
Study 19098076 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (white wine, men eight units, women six units)
Number of subjects: 10
Study 19098076 — intervention group
Group type: COMPARATOR
Intervention: Alcohol-free wine (control)
Number of subjects: 10
Study 16492134 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (30 mg)
Number of subjects: 29
Study 16492134 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 12736018 — intervention group
Group type: EXPERIMENTAL
Intervention: 22 mL of a 1% lidocaine solution injected into the neurovascular bundles, the genitourinary diaphragm, and between the rectal wall and prostate
Number of subjects: 50
Study 12736018 — intervention group
Group type: COMPARATOR
Intervention: 10 mL of 2% intrarectal lidocaine jelly
Number of subjects: 50
Study 11068978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus routine care (RC)
Number of subjects: 87
Study 11068978 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive counseling (SC) plus routine care (RC)
Number of subjects: 87
Study 11068978 — intervention group
Group type: COMPARATOR
Intervention: Routine care (RC) alone
Number of subjects: 87
Study 8839196 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate 180 mg
Number of subjects: 40
Study 8839196 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate 100 mg
Number of subjects: 40
Study 8839196 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate (both dosages)
Number of subjects: 40
Study 1451816 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 0
Study 1451816 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin (AT)
Number of subjects: 0
Study 1451816 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of low dose heparin and AT
Number of subjects: 0
Study 6587753 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 0
Study 2874067 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol
Number of subjects: 32
Study 2874067 — intervention group
Group type: COMPARATOR
Intervention: methyldopa
Number of subjects: 32
Study 30636672 — intervention group
Group type: EXPERIMENTAL
Intervention: Leech therapy (4-7 leeches, single session)
Number of subjects: 44
Study 30636672 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy (4 weekly sessions, 1 hour each)
Number of subjects: 44
Study 30636672 — intervention group
Group type: EXPERIMENTAL
Intervention: Leech therapy
Number of subjects: 44
Study 28281865 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 27
Study 28281865 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (PhD faculty)
Number of subjects: 27
Study 28281865 — intervention group
Group type: COMPARATOR
Intervention: Control group (MD faculty)
Number of subjects: 27
Study 28281865 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study 25699687 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal hypothermia before and for 3 hours after percutaneous coronary intervention
Number of subjects: 54
Study 25699687 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal hypothermia
Number of subjects: 54
Study 25699687 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 54
Study 24329506 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant growth hormone (rhGH) treatment for 2 years
Number of subjects: 94
Study 21124039 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly irinotecan-based therapy
Number of subjects: 601
Study 21124039 — intervention group
Group type: EXPERIMENTAL
Intervention: Biweekly irinotecan-based therapy
Number of subjects: 601
Study 21124039 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line therapy
Number of subjects: 601
Study 21124039 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy
Number of subjects: 601
Study 21124039 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-line therapy
Number of subjects: 601
Study 21124039 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-line therapy
Number of subjects: 601
Study 21124039 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 601
Study 21124039 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients <70 years old
Number of subjects: 601
Study 18376682 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline irrigation
Number of subjects: 200
Study 18376682 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine irrigation
Number of subjects: 200
Study 18376682 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine irrigation
Number of subjects: 200
Study 16343039 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate monotherapy
Number of subjects: 18
Study 16343039 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate + 10 mg folate
Number of subjects: 18
Study 16343039 — intervention group
Group type: COMPARATOR
Intervention: Fluvastatin (80 mg)
Number of subjects: 18
Study 12568856 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide (CO2)
Number of subjects: 189
Study 12568856 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 189
Study 10904122 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Sleep Deprivation (TSD) + Light Therapy (150 or 2500 lux)
Number of subjects: 115
Study 10904122 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Sleep Deprivation (TSD)
Number of subjects: 115
Study 10904122 — intervention group
Group type: EXPERIMENTAL
Intervention: Light Therapy
Number of subjects: 115
Study 10904122 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing Lithium Treatment
Number of subjects: 115
Study 10904122 — intervention group
Group type: EXPERIMENTAL
Intervention: TSD + Light Therapy
Number of subjects: 115
Study 8997650 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Tissue Regeneration (GTR) with expanded polytetrafluoroethylene membrane
Number of subjects: 28
Study 8997650 — intervention group
Group type: COMPARATOR
Intervention: Gingival Flap Surgery (GFS)
Number of subjects: 28
Study 8997650 — intervention group
Group type: COMPARATOR
Intervention: Comparison of GTR vs GFS
Number of subjects: 28
Study 1735865 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin surface modified intraocular lenses
Number of subjects: 266
Study 1735865 — intervention group
Group type: COMPARATOR
Intervention: Control intraocular lenses (PMMA without heparin)
Number of subjects: 266
Study 6520804 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and group discussion program
Number of subjects: 0
Study 6520804 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31205265 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programme (thrice weekly, supervised exercise on a static bike for six weeks)
Number of subjects: 16
Study 31205265 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-randomised cohort of LT patients receiving structured nutritional advice)
Number of subjects: 16
Study 29564973 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% 1RM (G20)
Number of subjects: 30
Study 29564973 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% 1RM (G40)
Number of subjects: 30
Study 29564973 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% 1RM (G60)
Number of subjects: 30